Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® (OMNI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02455024
Recruitment Status : Recruiting
First Posted : May 27, 2015
Last Update Posted : March 26, 2019
Sponsor:
Collaborator:
United BioSource Corporation
Information provided by (Responsible Party):
Takeda ( Ariad Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2020
Estimated Study Completion Date : September 30, 2020